Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer

Anne Benzinger1, Nemone Muster, Heike B Koch

  • 1Molecular Oncology, Max-Planck-Institute of Biochemistry, Am Klopferspitz 18, D-82152 Martinsried/Munich, Germany.

Insights

Researchers identified 117 proteins interacting with 14-3-3 sigma, revealing its broad role in cellular processes beyond cell cycle regulation. This highlights 14-3-3 sigma

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Cancer Research

Background:

  • 14-3-3 sigma is a protein involved in cell cycle regulation and apoptosis.
  • Its role in other cellular processes and its interactome in vivo are not fully understood.
  • Loss of 14-3-3 sigma expression is observed in various cancers.

Purpose of the Study:

  • To comprehensively identify proteins interacting with 14-3-3 sigma in human cells.
  • To understand the functional implications of these interactions in cellular processes and cancer.

Main Methods:

  • Tandem affinity purification combined with multidimensional protein identification technology (MudPIT).
  • Characterization of 117 identified 14-3-3 sigma-associated proteins.
  • Functional analysis of identified interactors and assessment of 14-3-3 sigma's effect on cellular migration and signaling.

Main Results:

  • Identified 117 proteins interacting with 14-3-3 sigma, with most containing potential binding sites.
  • Discovered 25 novel interacting proteins (SIP2-26) and 92 known proteins involved in oncogenic signaling and cell cycle regulation.
  • Identified functional classes related to cytoskeletal dynamics, polarity, adhesion, and mitogenic signaling; ectopic 14-3-3 sigma inhibited cell migration and enhanced MAPK signaling.

Conclusions:

  • 14-3-3 sigma interacts with a diverse set of proteins, influencing multiple cellular processes.
  • The findings suggest 14-3-3 sigma's role extends beyond cell cycle arrest, impacting cell motility and signaling.
  • Cancer-associated loss of 14-3-3 sigma may contribute to tumorigenesis through various pathways.